Alkylamine Chemicals announced its third quarter 2025 results on January 25, 2025: Profit increased by 30.9% year-on-year, with profit of 437.6 million rupees and revenue of 3712 million rupees.

Alkylamine Chemicals announced its third quarter 2025 results on January 25, 2025: Profit increased by 30.9% year-on-year, with profit of 437.6 million rupees and revenue of 3712 million rupees.

2025-01-25 11:51:00 :

Alkyl Amine Chemicals Third Quarter 2025 Results: Alkyl Amine Chemicals announced third quarter results on January 24, 2025. Revenue increased by 15.26% year-on-year, and profits soared by 30.9% year-on-year. The company reported profits of $4376 Crores with revenue of Rs. $371.2 Crores.

However, compared with the previous quarter, revenue fell by 10.53% and profit fell by 7.8%. The trend has raised some concerns among analysts about the company’s short-term performance.

Selling, general and administrative expenses decreased slightly by 2.47% month-on-month, but increased by 12.17% year-on-year, indicating higher long-term operating costs.

Despite the chain-on-month challenges, although operating income fell by 4%, it achieved an astonishing growth of 24.45% year-on-year. This suggests that alkylamines are still on a growth trajectory compared to last year.

Earnings per share (EPS) for the third quarter were $8.55, a significant increase of 30.93% year-over-year, reflecting strong underlying performance despite quarterly fluctuations.

Alkyl Amines Chemicals returned 0.89% last week, but has lost 12.4% over the past six months and has returned a paltry 0.1% so far this year.

The company’s current market capitalization is $9,019.12 million rupees, a new 52-week high $2498.85 and lowest price $1701.5, indicating some volatility in its stock performance.

Of the four analysts covering the company as of January 25, 2025, one has a Strong Sell rating, another a Sell rating, one a Hold rating and one a Buy rating . The mixed outlook points to divided views on the company’s future prospects.

As of January 25, 2025, the consensus recommendation was Sell, underscoring market analysts’ caution regarding the short-term outlook for alkylamine chemicals.

Alkylamine Chemicals Finance

periodQ3 (FY2025)Q2 (FY25)month-on-month growthQ3 (FY2024)year-on-year growth
total revenue371.2414.89-10.53%322.05+15.26%
Total Selling/General/Administrative Expenses26.0926.75-2.47%23.26+12.17%
Depreciation/Amortization17.9318.01-0.44%16.78+6.85%
total operating expenses317.9359.37-11.54%279.22+13.85%
operating income53.355.52-4%42.83+24.45%
net income before tax59.0564.33-8.21%46.33+27.46%
net income43.7647.46-7.8%33.43+30.9%
Diluted normalized earnings per share8.559.27-7.77%6.53+30.93%
Get the latest updates on quarterly results with our results calendar

Disclaimer: This is an AI-generated live blog and has not been edited by LiveMint staff.

Follow us On Social Media   Twitter/X

Join WhatsApp

Join Now